Table 2.
Demographic and clinical characteristics of subjects with MIS-A.
| Characteristics | Number of Patients (N = 79) | N (%) |
|---|---|---|
| Age [Mean ± SD] | Data available: 79 | 31.67±10.02 years |
| Gender | Data available: 79 | Males: 58 (73.4%) Females: 21 (26.6%) |
| Ethnicity Caucasian Hispanic Latin Asian African Afro-American |
Data available: 55/79 |
13 (23.6%) 12 (21.8%) 1 (1.8%) 14 (25.4%) 4 (7.3%) 11 (20%) |
| Clinical features Fever Dyspnea Cough Chest pain Nausea Vomiting Diarrhea Abdominal pain Skin rash Conjunctivitis Lymphadenopathy Confusion Peripheral Edema Myalgia Joint pain Headache Cracking of lips Sore throat Odynophagia |
Data available: 64/79 |
64 (100%) 20 (31.2%) 16 (25%) 8 (12.5%) 10 (15.6%) 16 (25%) 33 (51.6%) 26 (40.6%) 37 (57.8%) 26 (40.6%) 22 (34.3%) 4 (6.2%) 5 (7.8%) 25 (39.1%) 4 (6.2%) 16 (25%) 9 (14.1%) 2 (3.1%) 4 (6.2%) |
| Systemic involvement Cardiovascular Muco-cutaneous Gastrointestinal Musculoskeletal Renal Hematological Neurological Pulmonary |
Data available: 79/79 |
64 (81%) 41 (51.9%) 58 (73.4%) 24 (30.4%) 34 (43.1%) 33 (41.8%) 13 (16.4%) 23 (29.1%) |
| Comorbidities Hypertension Diabetes Dyslipidemia Obesity Coronary artery disease Asthma Malignancy Chronic kidney disease |
26 (32.9%) 10 6 2 17 1 2 4 3 |
|
| Duration of symptoms [Mean ± SD] | Data available: 58/79 | 5.84±8.01 days |
| Duration of hospital stay [Mean ± SD] | Data available: 59/79 | 11.67±8.08 days |
| Time between exposure and symptom onset [Mean ± SD] | Data available: 33/79 | 31.61±14.34 days |
| COVID-19 status Antibody positivity RTPCR positivity COVID-19 vaccination |
Data available: 68/79 Data available: 77/79 Data available: 79/79 |
58 (85.3%) 28 (36.4%) 2 (2.5%) |
Abbreviations: SD- Standard deviation, COVID-19- coronavirus disease, RTPCR- reverse transcriptase polymerase chain reaction.